SHL Telemedicine (NASDAQ:SHLT) Trading Up 23.7% – What’s Next?

SHL Telemedicine Ltd. (NASDAQ:SHLT)’s stock price shot up 23.7% on Tuesday . The stock traded as high as $3.87 and last traded at $3.50. 108,985 shares were traded during mid-day trading, an increase of 1,123% from the average session volume of 8,910 shares. The stock had previously closed at $2.83.

SHL Telemedicine Trading Down 0.7 %

The company has a current ratio of 2.17, a quick ratio of 1.98 and a debt-to-equity ratio of 0.19. The stock’s 50-day simple moving average is $2.84 and its 200-day simple moving average is $3.75.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in SHL Telemedicine stock. Y.D. More Investments Ltd purchased a new position in SHL Telemedicine Ltd. (NASDAQ:SHLT) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,219,610 shares of the company’s stock, valued at approximately $11,351,000. SHL Telemedicine accounts for about 1.2% of Y.D. More Investments Ltd’s investment portfolio, making the stock its 22nd largest position. Y.D. More Investments Ltd owned 15.12% of SHL Telemedicine at the end of the most recent reporting period. Hedge funds and other institutional investors own 20.11% of the company’s stock.

SHL Telemedicine Company Profile

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG.